Allied Healthcare Products, Inc.
AHPIQ
$0.00
$0.000.00%
| Weiss Ratings | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -153.35 | |||
| Price History | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Feb 27, 2024 | |||
| 52-Week High Price (Date) | May 08, 2024 | |||
| Valuation | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -1.35 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 4.01M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (312) 254-0880 | |||
| Address | 55 Monroe St. Chicago, IL 60603 | |||
| Website | www.alliedhpi.com | |||
| Country | United States | |||
| Year Founded | 1979 | |||
| Profitability | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -16.93% | |||
| Profit Margin | -19.82% | |||
| Management Effectiveness | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -15.32% | |||
| Return on Equity | -- | |||
| Income Statement | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 27.05M | |||
| Total Revenue (TTM) | 27.05M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 2.53M | |||
| EBITDA (TTM) | -4.13M | |||
| EBIT (TTM) | -4.58M | |||
| Net Income (TTM) | -5.36M | |||
| Net Income Avl. to Common (TTM) | -5.36M | |||
| Total Revenue Growth (Q YOY) | -14.31% | |||
| Earnings Growth (Q YOY) | -224.58% | |||
| EPS Diluted (TTM) | -1.35 | |||
| EPS Diluted Growth (Q YOY) | -226.58% | |||
| Balance Sheet | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.32M | |||
| Cash Per Share (Q) | $0.83 | |||
| Total Current Assets (Q) | 16.08M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.23M | |||
| Current Ratio (Q) | 2.688 | |||
| Book Value Per Share (Q) | $1.30 | |||
| Total Assets (Q) | 19.67M | |||
| Total Current Liabilities (Q) | 5.98M | |||
| Total Debt (Q) | 10.58M | |||
| Total Liabilities (Q) | 14.44M | |||
| Total Common Equity (Q) | 5.23M | |||
| Cash Flow | AHPIQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -75.00K | |||
| Cash from Financing (TTM) | 8.49M | |||
| Net Change in Cash (TTM) | 4.32M | |||
| Levered Free Cash Flow (TTM) | -4.36M | |||
| Cash from Operations (TTM) | -4.10M | |||
